Flu epidemic seems to be emerging More and more people in the Netherlands have the flu. The number of people with flu increased significantly last week.
RIVM monitoring local radiological measurements in Ukraine Reports from Ukraine indicate that there was fighting in the vicinity of the Zaporizhzhia nuclear power plant last night. RIVM has been actively monitoring the situation in Ukraine since the start of the disturbances.
General practitioners and occupational physicians not yet connected through Patiëntoverleg app General practitioners’ (GP) and occupational physicians’ (OP) use of the Patiëntoverleg app is still limited. They are often not yet aware of this app’s existence. These findings are from a study performed by RIVM.
RIVM calls for increased involvement of scientific community in solving plastic crisis Industry and policymakers are not availing themselves enough of the available scientific knowledge when it comes to smarter ways of dealing with plastics.
WHO Chemical Risk Assessment Workshop on new and emerging risks to human health from chemicals RIVM is hosting an international workshop on new and emerging risks from chemicals on 20 and 21 February 2019.
Possible health risks due to exposure to chromium-6 at tROM project Tilburg Research by RIVM shows that the participants in the so-called tROM project, their supervisors and other people involved may have been exposed to chromium-6.
Kick off European Project VITAL: Vaccines and InfecTious diseases in the Ageing popuLation Recently, the EU-sponsored Vaccines and InfecTious diseases in the Ageing popuLation (VITAL) project was launched.
Broad approach needed against pharmaceutical residues in environment We can all help to reduce pollution of the environment by pharmaceutical residues.
Icy air measurements Bernice Notenboom’s Arctic March expedition team has reached the summit of Greenland. She has conquered the 3500-metre high summit on Greenland with functioning air measuring equipment.
Vaccination using needles: there are alternatives Dr Hoang Hirschberg, employed at RIVM, has carried out PhD research into three alternatives for needle injections. She concluded that all alternatives have advantages and limitations.